Biofil shares in spotlight due to regulatory filing
Biofil shares in spotlight due to regulatory filing. The company has submitted a copy of newspaper publication as part of compliance under SEBI (LODR) Regulations, 2015 and Companies Act, 2013. This is a routine disclosure under Regulation 30, 44, and 47. No financial impact is expected from this compliance update.
📊 STOCKS: $BIOFILCHEM | 🏢 SECTOR: Pharma | #LOWIMPACT #RegulatoryFiling
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.